Paul Lee
Discovery Technologies, Amgen Inc., USA
Biography
Paul Lee joined Amgen Inc. in 2004. He currently leads a group of scientists and is responsible for developing biochemical and cellular assays, implement high-throughput screens and lead discovery in the early drug discovery process. Prior to joining Amgen, Paul held various positions at Pfizer, Pharmacia, and Glaxo-Wellcome for over 12 years. Paul received his Ph.D. in Pharmacology from University of Hong Kong and completed his postdoctoral training at NIH.
Abstract
Abstract : High-throughput metabolic stability assays using RapidFire and Accurate-Mass Spectrometry